Biblio

Export 1237 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Q
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M., “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M., “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
M. Ramos de Matos, Ferreira, C., Herukka, S. - K., Soininen, H., Janeiro, A., Santana, I., Baldeiras, I., Almeida, M. Rosário, Lleo, A., Dols-Icardo, O., Alcolea, D., Benussi, L., Binetti, G., Paterlini, A., Ghidoni, R., Nacmias, B., Meulenbroek, O., van Doorn, L. J. C. van Wa, H Kuiperi, B. J., Hausner, L., Waldemar, G., Simonsen, A. Hviid, Tsolaki, M., Gkatzima, O., de Oliveira, C. Resende, Verbeek, M. M., Clarimón, J., Hiltunen, M., de Mendonça, A., and Martins, M., “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
E. Makovac, Serra, L., Di Domenico, C., Marra, C., Caltagirone, C., Cercignani, M., and Bozzali, M., “Quantitative Magnetization Transfer of White Matter Tracts Correlates with Diffusion Tensor Imaging Indices in Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 561-575, 2018.
J. Ahdidan, Raji, C. A., DeYoe, E. A., Mathis, J., Noe, K. Ø., Rimestad, J., Kjeldsen, T. K., Mosegaard, J., Becker, J. T., and Lopez, O., “Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.”, J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
R
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
C. Dallaire-Théroux, Callahan, B. L., Potvin, O., Saikali, S., and Duchesne, S., “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
C. Dallaire-Théroux, Callahan, B. L., Potvin, O., Saikali, S., and Duchesne, S., “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
M. S. Rafii, Skotko, B. G., McDonough, M. Ellen, Pulsifer, M., Evans, C., Doran, E., Muranevici, G., Kesslak, P., Abushakra, S., and Lott, I. T., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
M. L. Sanders, Stuckenschneider, T., Devenney, K. E., Lawlor, B., Schneider, S., and Rikkert, M. G. M. Olde, “Real World Recruiting of Older Subjects with Mild Cognitive Impairment for Exercise Trials: Community Readiness is Pivotal.”, J Alzheimers Dis, vol. 62, no. 2, pp. 579-581, 2018.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
D. A. Loewenstein, Curiel, R. E., DeKosky, S., Rosselli, M., Bauer, R., Grieg-Custo, M., Penate, A., Li, C., Lizagarra, G., Golde, T., Adjouadi, M., and Duara, R., “Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 131-139, 2017.
D. A. Loewenstein, Curiel, R. E., DeKosky, S., Rosselli, M., Bauer, R., Grieg-Custo, M., Penate, A., Li, C., Lizagarra, G., Golde, T., Adjouadi, M., and Duara, R., “Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 131-139, 2017.
D. A. Loewenstein, Curiel, R. E., Wright, C., Sun, X., Alperin, N., Crocco, E., Czaja, S. J., Raffo, A., Penate, A., Melo, J., Capp, K., Gamez, M., and Duara, R., “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
R. García de Eulate, Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., and Fernández-Seara, M. A., “Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.”, J Alzheimers Dis, vol. 58, no. 2, pp. 585-595, 2017.
P. Squarzoni, Duran, F. Luis Souza, Busatto, G. F., and Alves, T. Correa Tol, “Reduced Gray Matter Volume of the Thalamus and Hippocampal Region in Elderly Healthy Adults with no Impact of APOE ɛ4: A Longitudinal Voxel-Based Morphometry Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 757-771, 2018.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., “Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
K. A. Tetzloff, Graff-Radford, J., Martin, P. R., Tosakulwong, N., Machulda, M. M., Duffy, J. R., Clark, H. M., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Drubach, D. A., Jack, C. R., Lowe, V. J., Josephs, K. A., and Whitwell, J. L., “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
K. A. Tetzloff, Graff-Radford, J., Martin, P. R., Tosakulwong, N., Machulda, M. M., Duffy, J. R., Clark, H. M., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Drubach, D. A., Jack, C. R., Lowe, V. J., Josephs, K. A., and Whitwell, J. L., “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
W. Gomm, von Holt, K., Thomé, F., Broich, K., Maier, W., Weckbecker, K., Fink, A., Doblhammer, G., and Haenisch, B., “Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.”, J Alzheimers Dis, vol. 54, no. 2, pp. 801-8, 2016.
R. Silva Paradela, Ferreira, N. Vidal, Nucci, M. Penteado, Cabella, B., Martino, L. Menoni, Torres, L. Aló, da Costa, D. Irigoyen, Consolim-Colombo, F. Marciano, Suemoto, C. Kimie, and Irigoyen, M. Claudia, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
B. L. R. Reijs, Ramakers, I. H. G. B., Elias-Sonnenschein, L., Teunissen, C. E., Koel-Simmelink, M., Tsolaki, M., Wahlund, L. - O., Waldemar, G., Hausner, L., Johannsen, P., Vanderstichele, H., Verhey, F., Devanand, D. P., and Visser, P. Jelle, “Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1025-1034, 2017.

Pages